Why the study?
Cardiogenic shock remains a leading cause of death in AMI with conventional mortality exceeding 50%, and ECLS may serve as a bridge to decision when standard management fails.
Does extracorporeal life support (ECLS) improve survival in patients with cardiogenic shock complicating acute myocardial infarction?
Does extracorporeal life support (ECLS) improve survival in patients with cardiogenic shock complicating acute myocardial infarction?
In patients with cardiogenic shock complicating acute myocardial infarction, ECLS support resulted in a 41.1% survival rate to hospital discharge.
No takes yet. Share an insight, caveat, or question.
ECLS in AMI cardiogenic shock yields modest survival; leaves open benefit versus medical therapy in randomized trials.
Pozzi et al. (2019) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: